FDA inspection
SmithKline Beecham Limited: FDA inspection ending Mar 18, 2011
FDA inspection 717039 · Official Action Indicated (OAI) · Worthing
Key facts
| Inspection ID | 717039 |
|---|---|
| Firm | SmithKline Beecham Limited |
| FEI number | 1000166776 |
| Address | Southdownview Way |
| City | Worthing |
| Country | United Kingdom |
| Fiscal year | 2011 |
| Inspection end date | Mar 18, 2011 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 214334 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data